Significant reduced loss of brain volume in MS patients
Posted: Wed Oct 12, 2011 4:12 am
Significant reduced loss of brain volume in MS patients treated with Copaxone
Results from a five-year study of treatment-naïve patients with relapsing-remitting multiple sclerosis (RRMS) demonstrated that patients treated with Copaxone (glatiramer acetate injection) showed significant reduced loss of brain volume compared to patients treated with other disease modifying therapies (DMTs).
Though all DMT treatment arms resulted in a reduction in brain volume loss compared to the control group of non-treated patients, Copaxone had a significantly better effect than both low and high dose interferons, in reducing loss of brain volume. A paper published by Dr. Omar Khan, detailing the study findings, "Effect of disease-modifying therapies on brain volume in relapsing-remitting multiple sclerosis: Results of a five-year brain MRI study," was recently published in the Journal of the Neurological Sciences.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1767
Results from a five-year study of treatment-naïve patients with relapsing-remitting multiple sclerosis (RRMS) demonstrated that patients treated with Copaxone (glatiramer acetate injection) showed significant reduced loss of brain volume compared to patients treated with other disease modifying therapies (DMTs).
Though all DMT treatment arms resulted in a reduction in brain volume loss compared to the control group of non-treated patients, Copaxone had a significantly better effect than both low and high dose interferons, in reducing loss of brain volume. A paper published by Dr. Omar Khan, detailing the study findings, "Effect of disease-modifying therapies on brain volume in relapsing-remitting multiple sclerosis: Results of a five-year brain MRI study," was recently published in the Journal of the Neurological Sciences.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1767